CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company
DBV Technologies S.A.
Sign in to watch- Ticker
- DBVTF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- France
- Entity type
- operating
- Phone
- 330155427878
- Business address
- 107 AVENUE DE LA REPUBLIQUE, CHATILLON, France
Securities
- DBVT American Depositary Shares Nasdaq
- DBVTF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-20 | Boucinha Virginie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +113,000 | 113,000 | ||
| 2023-11-20 | Tasse Daniel Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +806,672 | 806,672 | ||
| 2023-11-20 | Mohideen Pharis Chief Medical Officer | Grant or award | +35,000 | 84,439 | ||
| 2023-11-20 | Mohideen Pharis Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +215,000 | 215,000 | ||
| 2023-08-25 | MORRIS TIMOTHY E Director | Purchase | +12,000 | $1.52 | $18K | 12,000 |
| 2023-08-01 | SOLAND DANIEL B Director | Purchase | +15,000 | $1.62 | $24K | 20,000 |
| 2023-05-24 | Mohideen Pharis Chief Medical Officer | Sale | −469 | $3.54 | $2K | 49,439 |
| 2022-11-24 | Mohideen Pharis Chief Medical Officer | Sale | −1,792 | $2.88 | $5K | 49,908 |
| 2022-11-21 | Tasse Daniel Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +764,386 | 764,386 | ||
| 2022-11-21 | Mohideen Pharis Chief Medical Officer | Grant or award | +17,500 | 51,700 | ||
| 2022-11-21 | Mohideen Pharis Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +115,000 | 115,000 | ||
| 2022-11-21 | Robitaille Sebastien Chief Financial Officer | Grant or award | +8,000 | 36,500 | ||
| 2022-11-21 | Robitaille Sebastien Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2022-07-29 | Mohideen Pharis Chief Medical Officer | Grant or award | +10,000 | 34,200 | ||
| 2022-07-29 | Mohideen Pharis Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award | +1,252,432 | 1,585,054 | ||
| 2022-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award | +10,622,568 | 14,575,984 | ||
| 2022-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Pre-Funded Warrants | +1,383,352 | 1,383,352 | ||
| 2022-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Pre-Funded Warrants | +11,732,979 | 11,732,979 | ||
| 2021-11-22 | Tasse Daniel Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +274,000 | 274,000 |
Page 3 of 4 · 70 trades